Physician profile
Yoav Barnavon
NPI 1114972692
$23,877.28
in general payments reported to CMS, 2019-2025
38 companies · $9,420 in 2025
The $9,420 reported for 2025 was more than what 94% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,122 · 2020: $1,082 · 2021: $1,928 · 2022: $4,285 · 2023: $2,468 · 2024: $2,571 · 2025: $9,420.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,712 · Consulting Fee: $2,345 · Honoraria: $1,500 · Travel and Lodging: $809 · Gift: $87.00 · Education: $7.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,712.02 |
| Consulting Fee | $2,344.73 |
| Honoraria | $1,500.00 |
| Travel and Lodging | $808.87 |
| Gift | $87.00 |
| Education | $7.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Motiva USA, LLC | $5,164.17 | 2024-2025 | |
| Mentor Worldwide LLC | $2,466.01 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander |
| Tela Bio, INC. | $2,267.20 | 2020-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Surgical Innovation Associates, INC. | $2,146.58 | 2022 | |
| Bimini Technologies LLC | $1,500.00 | 2025 | |
| Musculoskeletal Transplant Foundation INC. | $1,213.51 | 2019-2025 | |
| Davol INC. | $1,201.82 | 2019-2025 | Phasix Mesh, Arista Ah Flexitip |
| Allergan, INC. | $900.95 | 2019-2022 | |
| Integra Lifesciences Corporation | $779.51 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Durasorb Monofilament Mesh |
| Abbvie INC. | $599.50 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Alloderm |
| Aroa Biosurgery Incorporated | $483.31 | 2022-2024 | |
| Tepha INC | $470.57 | 2019-2020 | |
| Axogen | $449.21 | 2019-2023 | Avance Nerve Graft |
| Sientra, INC. | $447.78 | 2019-2022 | |
| Bard Peripheral Vascular, INC. | $419.07 | 2021 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $380.89 | 2019-2025 | Renasys Touch, Pico 14 |
| Polynovo North America LLC | $376.75 | 2023-2025 | Novosorb Btm |
| Stryker Corporation | $317.57 | 2019-2024 | Spy-Phi System, 1788 |
| Avita Medical Americas, LLC | $317.43 | 2024-2025 | Permeaderm, Recell, Cohealyx |
| Endo Pharmaceuticals INC. | $295.61 | 2019-2023 | Xiaflex |
| Kci USA, INC. | $256.06 | 2019-2023 | V.A.C. Veraflo, Prevena |
| Kerecis Limited | $244.91 | 2023-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Eagle Pharmaceuticals, INC. | $204.65 | 2019-2023 | |
| Becton, Dickinson and Company | $181.07 | 2025 | Galaflex |
| Coopersurgical, INC. | $140.11 | 2019-2025 | Onetrac Lx |
| Ethicon US, LLC | $125.00 | 2019 | |
| Acelrx Pharmaceuticals, INC. | $103.59 | 2020 | |
| Medical Device Business Services, INC. | $88.50 | 2021 | |
| Acera Surgical, INC. | $66.58 | 2022-2025 | Restrata Wound Matrix |
| Solventum Corporation | $57.30 | 2024-2025 | Prevena, V.A.C. Veraflo Cleanse Choice, V.A.C.Ulta |
| Pacira Pharmaceuticals Incorporated | $36.01 | 2025 | Exparel |
| Biotissue Holdings INC. | $35.48 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $34.72 | 2022-2023 | Seglentis |
| Vertical Pharmaceuticals, LLC | $28.57 | 2024 | Dsuvia |
| Organogenesis INC. | $23.15 | 2022 | |
| Wright Medical Technology, INC. | $20.02 | 2019 | |
| Innovation Technologies INC | $18.21 | 2023 | Irrisept |
| Medtronic, INC. | $15.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yoav Barnavon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.